Literature DB >> 12811644

The success of data collection in the palliative setting--telephone or clinic follow-up?

Peiman Haddad1, Paula Wilson, Rebecca Wong, Diane Williams, Neena Sharma, Freidele Soban, Michael McLean, Wilfred Levin, Andrea Bezjak.   

Abstract

Assessment of outcomes is essential in order to improve available palliative treatments. Collecting follow-up information can be a challenging task in the palliative setting. We compared the effectiveness of data collection by telephone contact and clinic visit in 112 patients with brain metastases treated with whole-brain radiotherapy. The first 56 patients (group A) were followed by telephone only. The second 56 patients (group B) were asked to attend an outpatient clinic appointment 4 weeks after radiotherapy. Successful contact was defined as obtaining data at week 4. Patients in the two groups did not differ significantly with regard to age, sex, performance status, primary site, number of brain metastases, or the treatment given. The proportions of patients with successful follow-up contact at week 4 were 45% and 61% in groups A and B, respectively ( P = 0.09). The quality of the collected data did not differ significantly between the two groups. The side effects and responses to therapy were similar. However, there were significantly more patients with a reduced dose of dexamethasone among the successful contacts in group B, which probably reflected the better condition of the patients coming back to clinic at week 4. In conclusion, there was a trend towards more successful data collection in our clinic follow-up. Some of the observed outcome data suggest that the two methods of follow-up might be reaching different populations of patients; considering this and the high attrition rate, a combined follow-up strategy of clinic and telephone contacts might be the best strategy.

Entities:  

Mesh:

Year:  2003        PMID: 12811644     DOI: 10.1007/s00520-003-0485-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  10 in total

1.  Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation.

Authors:  P Rodrigus; P de Brouwer; E Raaymakers
Journal:  Lung Cancer       Date:  2001-05       Impact factor: 5.705

2.  Open access follow-up for lung cancer: patient and staff satisfaction.

Authors:  J W Adlard; J Joseph; C V Brammer; G E Gerrard
Journal:  Clin Oncol (R Coll Radiol)       Date:  2001       Impact factor: 4.126

3.  Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma.

Authors:  S Sardell; G Sharpe; S Ashley; D Guerrero; M Brada
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

4.  Follow up by telephone. Phone clinic provides excellent support.

Authors:  M Brada; N D James
Journal:  BMJ       Date:  1995-03-18

5.  Follow up by telephone.

Authors:  J N Rao
Journal:  BMJ       Date:  1994-12-10

6.  Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program. feasibility of telephone follow-up.

Authors:  E Chow; R Wong; R Connolly; G Hruby; E Franssen; K W Fung; M Vachon; L Andersson; J Pope; L Holden; E Szumacher; T Schueller; K Stefaniuk; J Finkelstein; C Hayter; C Danjoux
Journal:  J Pain Symptom Manage       Date:  2001-08       Impact factor: 3.612

7.  Radiotherapy for brain metastases: defining palliative response.

Authors:  A Bezjak; J Adam; T Panzarella; W Levin; R Barton; P Kirkbride; M McLean; W Mason; C S Wong; N Laperriere
Journal:  Radiother Oncol       Date:  2001-10       Impact factor: 6.280

Review 8.  Considerations in the diagnosis and management of brain metastases.

Authors:  R Sawaya
Journal:  Oncology (Williston Park)       Date:  2001-09       Impact factor: 2.990

9.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

10.  Symptom response after palliative radiotherapy for patients with brain metastases.

Authors:  A Bezjak; J Adam; R Barton; T Panzarella; N Laperriere; C S Wong; W Mason; C Buckley; W Levin; M McLean; J S Y Wu; M Sia; P Kirkbride
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

  10 in total
  6 in total

1.  Review of telephone follow-up experience at the Rapid Response Radiotherapy Program.

Authors:  Edward Chow; Kin-Wah Fung; Nicole Bradley; Lori Davis; Lori Holden; Cyril Danjoux
Journal:  Support Care Cancer       Date:  2004-11-05       Impact factor: 3.603

2.  Beyond palliative radiotherapy: a pilot multidisciplinary brain metastases clinic.

Authors:  Brita Danielson; Alysa Fairchild
Journal:  Support Care Cancer       Date:  2011-04-09       Impact factor: 3.603

3.  The rapid access palliative radiotherapy program: blueprint for initiation of a one-stop multidisciplinary bone metastases clinic.

Authors:  A Fairchild; E Pituskin; B Rose; S Ghosh; J Dutka; A Driga; P Tachynski; J Borschneck; L Gagnon; S Macdonnell; J Middleton; K Thavone; S Carstairs; D Brent; D Severin
Journal:  Support Care Cancer       Date:  2008-06-20       Impact factor: 3.603

4.  Communication with referring physicians in a palliative radiotherapy clinic.

Authors:  Elizabeth A Barnes; Edward Chow; Lou Andersson; Charles Hayter; Andrew Loblaw; David Lee; Lori Holden; Grace Chan; Cyril Danjoux
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

5.  Telephone interventions for symptom management in adults with cancer.

Authors:  Emma Ream; Amanda Euesden Hughes; Anna Cox; Katy Skarparis; Alison Richardson; Vibe H Pedersen; Theresa Wiseman; Angus Forbes; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2020-06-02

Review 6.  The Extent of Engagement With Telehealth Approaches by Patients With Advanced Cancer: Systematic Review.

Authors:  William Goodman; Anne-Marie Bagnall; Laura Ashley; Desiree Azizoddin; Felix Muehlensiepen; David Blum; Michael I Bennett; Matthew Allsop
Journal:  JMIR Cancer       Date:  2022-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.